FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128423735> ?p ?o ?g. }

• W2128423735 endingPage "1281" @default.
• W2128423735 startingPage "1276" @default.
• W2128423735 abstract "Worldwide, more than 28 million people live with cancer. This number could triple by 2030. With the increasing number of patients with cancer and improvements in cancer management that continue to reduce cancer death rates, the number of cancer survivors is projected to increase rapidly, in particular, those afflicted during childhood. In children and adolescents, the survival rate has jumped from fewer than 50% in the mid-1970s to 80% today. The growing population of childhood survivors is notable for its vulnerability to adverse health outcomes, many of which may not become clinically apparent until years after the completion of therapy. Despite surviving their initial cancer, childhood cancer survivors continue to face considerable premature mortality as adults. The excess risk of dying from other causes that contributes most to loss of life expectancy is the increased incidence of chronic conditions among survivors of childhood cancer. We need to monitor the health of these survivors and to minimize the use of therapies with late toxicities in newly diagnosed patients. Survivors also experience a higher prevalence of chronic conditions, with as many as two thirds of childhood cancer survivors reporting at least one chronic condition and one fourth reporting a severe, disabling, or life-threatening condition. Survivors of childhood cancer are 5 to 10 times more likely than their healthy siblings to experience heart disease. The incidence of these conditions increases with time, so the full extent of disease- and treatment-related late effects has yet to be realized. Survivors of childhood cancer are a new, large, emerging population at risk for acquired premature symptomatic cardiovascular disease. The report by Tukenova et al 1 provides important information on late excess cardiovascular mortality in childhood cancer survivors and on the factors associated with this mortality. Their report adds new information about late cardiac effects in childhood cancer survivors by specifically using carefully calculated radiation doses to the heart as a factor to assess overall mortality and cardiovascular mortality. Importantly, this study also evaluated the potential classes of medications for their association with cardiovascular mortality. This article not only validates previous studies of overall cardiac mortality, 2-7 it also provides new data on cumulative anthracycline dose, cumulative radiation dose, and the contribution of other agents. Although the dose-dependent risk of congestive heart failure and related deaths associated with anthracyclines among childhood cancer survivors is established, and although radiation exposure to the heart has also been associated with increased risk of cardiovascular disease, this article’s evaluation of the association between the dose of radiation and the dose of anthracyclines on cardiovascular mortality in the same cohort is important. Studies have generally looked only at radiation as a dichotomous variable, although others have looked at treat" @default.
• W2128423735 created "2016-06-24" @default.
• W2128423735 creator A5079462466 @default.
• W2128423735 creator A5082899595 @default.
• W2128423735 date "2010-03-10" @default.
• W2128423735 modified "2023-09-30" @default.
• W2128423735 title "Cardiotoxicity After Childhood Cancer: Beginning With the End in Mind" @default.
• W2128423735 cites W1769610184 @default.
• W2128423735 cites W1826795286 @default.
• W2128423735 cites W1867092966 @default.
• W2128423735 cites W1894979576 @default.
• W2128423735 cites W1913539970 @default.
• W2128423735 cites W1916063969 @default.
• W2128423735 cites W1917585376 @default.
• W2128423735 cites W1935834387 @default.
• W2128423735 cites W1949633840 @default.
• W2128423735 cites W1966825452 @default.
• W2128423735 cites W1971435493 @default.
• W2128423735 cites W1975506877 @default.
• W2128423735 cites W1976717056 @default.
• W2128423735 cites W1977566662 @default.
• W2128423735 cites W1988228415 @default.
• W2128423735 cites W1990736254 @default.
• W2128423735 cites W1996174269 @default.
• W2128423735 cites W2003943979 @default.
• W2128423735 cites W2009388600 @default.
• W2128423735 cites W2009687511 @default.
• W2128423735 cites W2011242979 @default.
• W2128423735 cites W2012998433 @default.
• W2128423735 cites W2015758016 @default.
• W2128423735 cites W2016926586 @default.
• W2128423735 cites W2018727646 @default.
• W2128423735 cites W2035843644 @default.
• W2128423735 cites W2040951283 @default.
• W2128423735 cites W2041336328 @default.
• W2128423735 cites W2044934343 @default.
• W2128423735 cites W2048889617 @default.
• W2128423735 cites W2055791127 @default.
• W2128423735 cites W2058337944 @default.
• W2128423735 cites W2061597353 @default.
• W2128423735 cites W2078927048 @default.
• W2128423735 cites W2079603148 @default.
• W2128423735 cites W2084196088 @default.
• W2128423735 cites W2088188667 @default.
• W2128423735 cites W2091972238 @default.
• W2128423735 cites W2095431493 @default.
• W2128423735 cites W2101119007 @default.
• W2128423735 cites W2116610563 @default.
• W2128423735 cites W2118715207 @default.
• W2128423735 cites W2121403869 @default.
• W2128423735 cites W2121688189 @default.
• W2128423735 cites W2121797481 @default.
• W2128423735 cites W2124074262 @default.
• W2128423735 cites W2125052019 @default.
• W2128423735 cites W2136546051 @default.
• W2128423735 cites W2142212384 @default.
• W2128423735 cites W2153787064 @default.
• W2128423735 cites W2160819972 @default.
• W2128423735 cites W2161082810 @default.
• W2128423735 cites W2164159671 @default.
• W2128423735 cites W2166342496 @default.
• W2128423735 cites W2252303868 @default.
• W2128423735 cites W2264195222 @default.
• W2128423735 cites W4232261981 @default.
• W2128423735 cites W4301026838 @default.
• W2128423735 doi "https://doi.org/10.1200/jco.2009.26.5751" @default.
• W2128423735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20142585" @default.
• W2128423735 hasPublicationYear "2010" @default.
• W2128423735 type Work @default.
• W2128423735 sameAs 2128423735 @default.
• W2128423735 citedByCount "125" @default.
• W2128423735 countsByYear W21284237352012 @default.
• W2128423735 countsByYear W21284237352013 @default.
• W2128423735 countsByYear W21284237352014 @default.
• W2128423735 countsByYear W21284237352015 @default.
• W2128423735 countsByYear W21284237352016 @default.
• W2128423735 countsByYear W21284237352017 @default.
• W2128423735 countsByYear W21284237352018 @default.
• W2128423735 countsByYear W21284237352019 @default.
• W2128423735 countsByYear W21284237352020 @default.
• W2128423735 countsByYear W21284237352021 @default.
• W2128423735 countsByYear W21284237352022 @default.
• W2128423735 countsByYear W21284237352023 @default.
• W2128423735 crossrefType "journal-article" @default.
• W2128423735 hasAuthorship W2128423735A5079462466 @default.
• W2128423735 hasAuthorship W2128423735A5082899595 @default.
• W2128423735 hasBestOaLocation W21284237351 @default.
• W2128423735 hasConcept C121608353 @default.
• W2128423735 hasConcept C126322002 @default.
• W2128423735 hasConcept C187212893 @default.
• W2128423735 hasConcept C2776694085 @default.
• W2128423735 hasConcept C2778233292 @default.
• W2128423735 hasConcept C2992894027 @default.
• W2128423735 hasConcept C71924100 @default.
• W2128423735 hasConceptScore W2128423735C121608353 @default.
• W2128423735 hasConceptScore W2128423735C126322002 @default.
• W2128423735 hasConceptScore W2128423735C187212893 @default.
• W2128423735 hasConceptScore W2128423735C2776694085 @default.

• next